121 related articles for article (PubMed ID: 28427211)
1. Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome.
Korpanty GJ; Eng L; Qiu X; Faluyi OO; Renouf DJ; Cheng D; Patel D; Chen Z; Tse BC; Knox JJ; Dodbiba L; Teichman J; Azad AK; Wong R; Darling G; Reisman D; Cuffe S; Liu G; Xu W
Oncotarget; 2017 Apr; 8(17):28093-28100. PubMed ID: 28427211
[TBL] [Abstract][Full Text] [Related]
2. BRM polymorphisms, pancreatic cancer risk and survival.
Segedi M; Anderson LN; Espin-Garcia O; Borgida A; Bianco T; Cheng D; Chen Z; Patel D; Brown MC; Xu W; Reisman D; Gallinger S; Cotterchio M; Hung R; Liu G; Cleary SP
Int J Cancer; 2016 Dec; 139(11):2474-81. PubMed ID: 27487558
[TBL] [Abstract][Full Text] [Related]
3. BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.
Liu G; Cuffe S; Liang S; Azad AK; Cheng L; Brhane Y; Qiu X; Cescon DW; Bruce J; Chen Z; Cheng D; Patel D; Tse BC; Laurie SA; Goss G; Leighl NB; Hung R; Bradbury PA; Seymour L; Shepherd FA; Tsao MS; Chen BE; Xu W; Reisman DN
Clin Cancer Res; 2017 May; 23(10):2460-2470. PubMed ID: 27827316
[No Abstract] [Full Text] [Related]
4. Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
Pasic I; Wong KM; Lee JJ; Espin-Garcia O; Brhane Y; Cheng D; Chen Z; Patel D; Brown C; Bucur R; Reisman D; Knox JJ; Xu W; Hung RJ; Liu G; Cleary SP
Mol Carcinog; 2018 Jan; 57(1):106-113. PubMed ID: 28892201
[TBL] [Abstract][Full Text] [Related]
5. Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
Lee MJ; Kuehne N; Hueniken K; Liang S; Rai S; Sorotsky H; Herman M; Shepshelovich D; Bruce J; Liang M; Patel D; Cheng D; Chen Z; Eng L; Brown MC; Cho J; Leighl NB; de Perrot M; Reisman D; Xu W; Bradbury PA; Liu G
Mol Carcinog; 2019 Nov; 58(11):1960-1973. PubMed ID: 31355511
[TBL] [Abstract][Full Text] [Related]
6. Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.
Wong KM; Qiu X; Cheng D; Azad AK; Habbous S; Palepu P; Mirshams M; Patel D; Chen Z; Roberts H; Knox J; Marquez S; Wong R; Darling G; Waldron J; Goldstein D; Leighl N; Shepherd FA; Tsao M; Der S; Reisman D; Liu G
Cancer Med; 2014 Apr; 3(2):426-33. PubMed ID: 24519853
[TBL] [Abstract][Full Text] [Related]
7. Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
Eng L; Azad AK; Qiu X; Kong QQ; Cheng D; Ying N; Tse A; Kuang Q; Dodbiba L; Renouf DJ; Marsh S; Savas S; Mackay HJ; Knox JJ; Darling GE; Wong RK; Xu W; Liu G; Faluyi OO
Carcinogenesis; 2015 Sep; 36(9):956-62. PubMed ID: 26014353
[TBL] [Abstract][Full Text] [Related]
8. Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk.
Wang JR; Gramling SJ; Goldstein DP; Cheng D; Chen D; Azad AK; Tse A; Hon H; Chen Z; Mirshams M; Simpson C; Huang SH; Marquez S; O'Sullivan B; Liu FF; Roberts H; Xu W; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Reisman DN; Liu G
Carcinogenesis; 2013 May; 34(5):1012-7. PubMed ID: 23322154
[TBL] [Abstract][Full Text] [Related]
9. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
10. Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.
Yu Y; Cheng D; Parfrey P; Liu G; Savas S
PLoS One; 2018; 13(6):e0198873. PubMed ID: 29894502
[TBL] [Abstract][Full Text] [Related]
11. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
[TBL] [Abstract][Full Text] [Related]
12. Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.
Faluyi OO; Eng L; Qiu X; Che J; Zhang Q; Cheng D; Ying N; Tse A; Kuang Q; Dodbiba L; Renouf DJ; Marsh S; Savas S; Mackay HJ; Knox JJ; Darling GE; Wong RK; Xu W; Azad AK; Liu G
Cancer Med; 2017 Feb; 6(2):361-373. PubMed ID: 28074552
[TBL] [Abstract][Full Text] [Related]
13. Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk.
Liu G; Gramling S; Munoz D; Cheng D; Azad AK; Mirshams M; Chen Z; Xu W; Roberts H; Shepherd FA; Tsao MS; Reisman D
Oncogene; 2011 Jul; 30(29):3295-304. PubMed ID: 21478907
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus.
Boonstra JJ; van Marion R; Tilanus HW; Dinjens WN
J Gastrointest Surg; 2011 Jan; 15(1):48-56. PubMed ID: 20922573
[TBL] [Abstract][Full Text] [Related]
15. Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations.
Gao X; Huang M; Liu L; He Y; Yu Q; Zhao H; Zhou C; Zhang J; Zhu Z; Wan J; Jiang X; Gao Y
PLoS One; 2013; 8(1):e55169. PubMed ID: 23359823
[TBL] [Abstract][Full Text] [Related]
16. Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.
Alakus H; Bollschweiler E; Hölscher AH; Warnecke-Eberz U; Frazer KA; Harismendy O; Lowy AM; Mönig SP; Eberz PM; Maus M; Drebber U; Siffert W; Metzger R
Ann Surg Oncol; 2014 Dec; 21(13):4375-82. PubMed ID: 24986238
[TBL] [Abstract][Full Text] [Related]
17. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
18. Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival.
Spreafico A; Coate L; Zhai R; Xu W; Chen ZF; Chen Z; Patel D; Tse B; Brown MC; Heist RS; Dodbiba L; Teichman J; Kulke M; Su L; Eng L; Knox J; Wong R; Darling GE; Christiani DC; Liu G
Cancer Epidemiol; 2017 Apr; 47():28-34. PubMed ID: 28088657
[TBL] [Abstract][Full Text] [Related]
19. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
Izzo JG; Wu TT; Wu X; Ensor J; Luthra R; Pan J; Correa A; Swisher SG; Chao CK; Hittelman WN; Ajani JA
J Clin Oncol; 2007 Feb; 25(6):698-707. PubMed ID: 17308274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
